June 24, 2009 — On June 17, the US Food and Drug Administration (FDA) approved diclofenac potassium for oral solution (Cambia, marketed by Kowa Pharmaceuticals America, Inc, under license from Applied ...
Camber is offering sodium sulfate, potassium sulfate and magnesium sulfate oral solution. Sodium sulfate, potassium sulfate and magnesium sulfate oral solution is an osmotic laxative indicated for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results